After the Nobel, What Next for CRISPR Gene-editing Therapies?

February 21, 2021

CRISPR has transformed the possibilities for curing diseases caused by one or several genetic mutations. Clinical trials for therapies that utilize the genome editing technology are already underway for debilitating conditions such as sickle-cell anemia, delivering treatments in disease areas where none currently exist.

Read the original article in The Guardian.

View CRISPR Speakers

“The Code Breaker”: Jennifer Doudna and how CRISPR may revolutionize mankind

Books

Walter Isaacson, the bestselling author of Leonardo da Vinci and Steve Jobs, returns to tell the story of Nobel Prize winner Jennifer Doudna and the scientific revolution she and her colleagues launched by developing CRISPR genome editing technology in The Code Breaker: Jennifer Doudna, CRISPR, and the Future of the Human Race.